<DOC>
	<DOC>NCT00790660</DOC>
	<brief_summary>This study is intended to assess safety and tolerability of ASP1941 compared to placebo in adult subjects with type 2 diabetes mellitus</brief_summary>
	<brief_title>A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.</brief_title>
	<detailed_description>Trial includes a two week washout period before entering the treatment period for subjects on oral anti-diabetic medication.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Established diagnosis of type 2 diabetes mellitus HbA1c value between 7.0 and 10.0% Body mass index between 20 and 45 kg/m2 Established diagnosis of type 1 diabetes mellitus Serum creatinine &gt; upper limit of normal range Proteinuria (microalbumin/creatinine ratio &gt; 300 mg/g) Urinary tract infection Severe uncontrolled Hypertension Significant renal, hepatic or cardiovascular disease HIV Positive History of drug or alcohol abuse/dependency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>ASP1941</keyword>
</DOC>